Back to all webinars
Treatment options for NSCLC when neoadjuvant chemo-IO does not achieve pCR
Sandip Patel and Salma Jabbour discuss the importance of achieving pCR and the role of cfDNA in monitoring disease.
Speakers
Neoadjuvant chemoimmunotherapy in NSCLC
No entries
Discussion: pCR as a clinical endpoint and the role of post-operative radiotherapy
No entries
The role of cell-free DNA in monitoring disease
No entries
Panel discussion and summary
No entries